OR2T33
gene geneOn this page
Summary
OR2T33 (olfactory receptor family 2 subfamily T member 33, HGNC:31255) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2T33 (Q8NG76). Odorant receptor. It is a selective cancer dependency (DepMap: 60.0% of cell lines).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 391195 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 71 total
- Cancer dependency (DepMap): dependent in 60.0% of screened cell lines
- MANE Select transcript:
NM_001004695
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31255 |
| Approved symbol | OR2T33 |
| Name | olfactory receptor family 2 subfamily T member 33 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000177212 |
| Ensembl biotype | protein_coding |
| Entrez | 391195 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000318021, ENST00000641220
RefSeq mRNA: 1 — MANE Select: NM_001004695
NM_001004695
CCDS: CCDS31109
Canonical transcript exons
ENST00000641220 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003814154 | 248277765 | 248277976 |
| ENSE00003814191 | 248269917 | 248273822 |
Expression profiles
Bgee: expression breadth broad, 22 present calls, max score 76.66.
Top tissues by expression
105 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.66 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.26 | gold quality |
| monocyte | CL:0000576 | 55.06 | gold quality |
| leukocyte | CL:0000738 | 54.29 | gold quality |
| stromal cell of endometrium | CL:0002255 | 47.89 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.97 | gold quality |
| bone marrow | UBERON:0002371 | 43.94 | gold quality |
| blood | UBERON:0000178 | 43.66 | gold quality |
| endometrium | UBERON:0001295 | 43.54 | gold quality |
| vermiform appendix | UBERON:0001154 | 43.29 | gold quality |
| placenta | UBERON:0001987 | 42.81 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 41.78 | gold quality |
| thyroid gland | UBERON:0002046 | 41.54 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 40.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 40.56 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 40.48 | silver quality |
| cortical plate | UBERON:0005343 | 40.00 | gold quality |
| ventricular zone | UBERON:0003053 | 39.90 | gold quality |
| prefrontal cortex | UBERON:0000451 | 39.78 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 39.68 | silver quality |
| muscle of leg | UBERON:0001383 | 38.66 | gold quality |
| islet of Langerhans | UBERON:0000006 | 38.58 | gold quality |
| gall bladder | UBERON:0002110 | 38.38 | gold quality |
| lymph node | UBERON:0000029 | 38.30 | gold quality |
| liver | UBERON:0002107 | 38.23 | gold quality |
| primary visual cortex | UBERON:0002436 | 38.16 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 38.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 37.87 | gold quality |
| frontal cortex | UBERON:0001870 | 36.67 | gold quality |
| granulocyte | CL:0000094 | 36.33 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.77 |
| E-MTAB-6386 | no | 79.77 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 60.0% of screened cell lines.
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2t44 | ENSMUSG00000059504 |
| rattus_norvegicus | Or2t44b | ENSRNOG00000033492 |
| rattus_norvegicus | Or2t44 | ENSRNOG00000084778 |
| rattus_norvegicus | Olr1454 | ENSRNOG00000089012 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 2T33 — Q8NG76 (reviewed: Q8NG76)
Alternative names: Olfactory receptor OR1-56
All UniProt accessions (1): Q8NG76
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004695* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NG76-F1 | 88.47 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 95–187
Glycosylation sites (1): 17
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 25 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, LAMB3_TARGET_GENES, REACTOME_SENSORY_PERCEPTION, GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
158 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2T33 | TAS2R13 | Q9NYV9 | 528 |
| OR2T33 | TAS2R5 | Q9NYW4 | 505 |
| OR2T33 | TAS2R50 | P59544 | 505 |
| OR2T33 | VN1R4 | Q7Z5H5 | 479 |
| OR2T33 | GOLGA6L6 | A8MZA4 | 474 |
| OR2T33 | GOLGA6L1 | Q8N7Z2 | 450 |
| OR2T33 | TAS2R10 | Q9NYW0 | 447 |
| OR2T33 | VN1R2 | Q8NFZ6 | 447 |
| OR2T33 | TAS2R14 | Q9NYV8 | 447 |
| OR2T33 | TAS2R43 | P59537 | 446 |
| OR2T33 | PPIAL4G | P0DN37 | 436 |
| OR2T33 | VN1R1 | Q9GZP7 | 391 |
| OR2T33 | TRIML1 | Q8N9V2 | 370 |
| OR2T33 | LYPD5 | Q6UWN5 | 370 |
| OR2T33 | TAS2R4 | Q9NYW5 | 360 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR2T33 | ANKLE2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): ANKLE2 (Affinity Capture-MS), OR2T12 (Affinity Capture-MS)
ESM2 similar proteins: A6NH00, O60403, O95371, O95918, P23266, P23267, P23275, P34984, P47881, P47888, P47893, Q15619, Q5JQS5, Q5TZ20, Q60885, Q60891, Q60894, Q6IEZ7, Q7Z3T1, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGC4, Q8NGE3, Q8NGE9, Q8NGQ2, Q8NGQ4, Q8NGR4, Q8NGS0, Q8NGT9, Q8NGX9, Q8NGY1, Q8NGZ6, Q8NH02, Q8NH03, Q8NH04, Q8NHB1, Q8VGD6
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
395 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248273166:CA:C | acceptor_gain | 0.7700 |
| 1:248272949:C:CC | acceptor_gain | 0.7200 |
| 1:248273167:A:C | acceptor_gain | 0.7200 |
| 1:248273554:A:AC | donor_gain | 0.7100 |
| 1:248273555:C:CC | donor_gain | 0.7100 |
| 1:248273223:A:AC | donor_gain | 0.6900 |
| 1:248273224:C:CC | donor_gain | 0.6900 |
| 1:248273167:A:AC | acceptor_gain | 0.6800 |
| 1:248273495:C:CT | donor_gain | 0.6800 |
| 1:248272945:CACA:C | acceptor_gain | 0.6700 |
| 1:248273496:C:CT | donor_gain | 0.6700 |
| 1:248273557:T:TA | donor_gain | 0.6700 |
| 1:248272947:CA:C | acceptor_gain | 0.6600 |
| 1:248273167:A:T | acceptor_gain | 0.6500 |
| 1:248273268:CCAG:C | donor_gain | 0.6500 |
| 1:248273154:C:CT | acceptor_gain | 0.6300 |
| 1:248273267:A:AC | donor_gain | 0.6300 |
| 1:248273268:C:CC | donor_gain | 0.6300 |
| 1:248273555:CTT:C | donor_gain | 0.6200 |
| 1:248273165:CCA:C | acceptor_gain | 0.6100 |
| 1:248273262:AACG:A | donor_loss | 0.6100 |
| 1:248273263:ACGC:A | donor_loss | 0.6100 |
| 1:248273264:CGCA:C | donor_loss | 0.6100 |
| 1:248273265:GCA:G | donor_loss | 0.6100 |
| 1:248273266:CA:C | donor_loss | 0.6100 |
| 1:248273725:CAGA:C | donor_gain | 0.6100 |
| 1:248273726:AGAA:A | donor_gain | 0.6100 |
| 1:248273127:C:CC | acceptor_gain | 0.6000 |
| 1:248273261:AAAC:A | donor_loss | 0.6000 |
| 1:248272946:ACA:A | acceptor_gain | 0.5800 |
AlphaMissense
2098 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:248272948:A:C | S289R | 0.880 |
| 1:248272948:A:T | S289R | 0.880 |
| 1:248272950:T:G | S289R | 0.880 |
| 1:248273785:A:C | F10L | 0.878 |
| 1:248273785:A:T | F10L | 0.878 |
| 1:248273787:A:G | F10L | 0.878 |
| 1:248273290:G:C | F175L | 0.864 |
| 1:248273290:G:T | F175L | 0.864 |
| 1:248273292:A:G | F175L | 0.864 |
| 1:248273236:G:C | F193L | 0.841 |
| 1:248273236:G:T | F193L | 0.841 |
| 1:248273238:A:G | F193L | 0.841 |
| 1:248273068:A:C | F249L | 0.832 |
| 1:248273068:A:T | F249L | 0.832 |
| 1:248273070:A:G | F249L | 0.832 |
| 1:248273287:G:C | F176L | 0.826 |
| 1:248273287:G:T | F176L | 0.826 |
| 1:248273289:A:G | F176L | 0.826 |
| 1:248273467:C:A | M116I | 0.795 |
| 1:248273467:C:G | M116I | 0.795 |
| 1:248273467:C:T | M116I | 0.795 |
| 1:248273722:A:C | S31R | 0.794 |
| 1:248273722:A:T | S31R | 0.794 |
| 1:248273724:T:G | S31R | 0.794 |
| 1:248273767:A:C | F16L | 0.773 |
| 1:248273767:A:T | F16L | 0.773 |
| 1:248273769:A:G | F16L | 0.773 |
| 1:248272990:G:C | F275L | 0.769 |
| 1:248272990:G:T | F275L | 0.769 |
| 1:248272992:A:G | F275L | 0.769 |
dbSNP variants (sampled 300 via entrez): RS1000342772 (1:248269634 T>C), RS1000774481 (1:248269882 T>C), RS1000802094 (1:248279432 C>G), RS1002350253 (1:248273105 G>A), RS1002381457 (1:248273714 A>C,G), RS1002718260 (1:248275135 T>C), RS1004124574 (1:248269530 T>C), RS1004319955 (1:248275575 C>T), RS1005697453 (1:248270406 C>T), RS1005797378 (1:248271019 A>T), RS1005952955 (1:248278987 T>C), RS1006027997 (1:248271751 T>C), RS1006028905 (1:248277435 T>C), RS1006336283 (1:248278713 A>G), RS1006714197 (1:248277544 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| 2-palmitoylglycerol | increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.